Here, we review the growing literature concerning the role of BVR-A in metabolic and neurodegenerative diseases, aiming to highlight key observations and experimental data from studies conducted both in animal models and in humans, focused on the link between BVR-A dysregulation and insulin signaling alterations in metabolic disorders and neurodegenerative diseases. The gene discussed is INS; the disease is neurodegenerative disease.